Becton Dickinson Quick Ratio 2010-2023 | BDX
Historical quick ratio values for Becton Dickinson (BDX) over the last 10 years.
| Becton Dickinson Quick Ratio Historical Data |
| Date |
Current Assets - Inventory |
Current Liabilities |
Quick Ratio |
| 2023-12-31 |
$4.85B |
$7.54B |
0.64 |
| 2023-09-30 |
$5.40B |
$6.64B |
0.81 |
| 2023-06-30 |
$5.00B |
$6.88B |
0.73 |
| 2023-03-31 |
$5.93B |
$7.30B |
0.81 |
| 2022-12-31 |
$4.57B |
$7.63B |
0.60 |
| 2022-09-30 |
$4.92B |
$7.81B |
0.63 |
| 2022-06-30 |
$6.38B |
$7.08B |
0.90 |
| 2022-03-31 |
$6.89B |
$6.66B |
1.04 |
| 2021-12-31 |
$5.27B |
$6.74B |
0.78 |
| 2021-09-30 |
$6.10B |
$6.63B |
0.92 |
| 2021-06-30 |
$6.59B |
$7.75B |
0.85 |
| 2021-03-31 |
$7.11B |
$5.38B |
1.32 |
| 2020-12-31 |
$6.72B |
$7.02B |
0.96 |
| 2020-09-30 |
$6.23B |
$5.84B |
1.07 |
| 2020-06-30 |
$5.88B |
$6.07B |
0.97 |
| 2020-03-31 |
$5.76B |
$8.76B |
0.66 |
| 2019-12-31 |
$3.68B |
$6.73B |
0.55 |
| 2019-09-30 |
$4.09B |
$5.66B |
0.72 |
| 2019-06-30 |
$4.15B |
$6.24B |
0.67 |
| 2019-03-31 |
$4.22B |
$7.11B |
0.59 |
| 2018-12-31 |
$4.42B |
$7.15B |
0.62 |
| 2018-09-30 |
$4.96B |
$7.22B |
0.69 |
| 2018-06-30 |
$4.96B |
$6.11B |
0.81 |
| 2018-03-31 |
$4.97B |
$4.43B |
1.12 |
| 2017-12-31 |
$4.58B |
$4.90B |
0.94 |
| 2017-09-30 |
$16.82B |
$3.34B |
5.03 |
| 2017-06-30 |
$16.38B |
$3.27B |
5.01 |
| 2017-03-31 |
$3.14B |
$4.02B |
0.78 |
| 2016-12-31 |
$3.50B |
$4.57B |
0.77 |
| 2016-09-30 |
$4.65B |
$4.40B |
1.06 |
| 2016-06-30 |
$4.70B |
$4.22B |
1.11 |
| 2016-03-31 |
$4.77B |
$4.38B |
1.09 |
| 2015-12-31 |
$3.66B |
$4.53B |
0.81 |
| 2015-09-30 |
$3.70B |
$4.38B |
0.85 |
| 2015-06-30 |
$4.28B |
$4.52B |
0.95 |
| 2015-03-31 |
$4.72B |
$4.50B |
1.05 |
| 2014-12-31 |
$10.60B |
$2.08B |
5.09 |
| 2014-09-30 |
$4.64B |
$2.24B |
2.07 |
| 2014-06-30 |
$4.49B |
$2.09B |
2.15 |
| 2014-03-31 |
$4.43B |
$2.02B |
2.20 |
| 2013-12-31 |
$4.28B |
$2.00B |
2.14 |
| 2013-09-30 |
$4.47B |
$2.13B |
2.10 |
| 2013-06-30 |
$4.03B |
$1.69B |
2.38 |
| 2013-03-31 |
$4.11B |
$1.88B |
2.19 |
| 2012-12-31 |
$4.12B |
$2.00B |
2.06 |
| 2012-09-30 |
$4.08B |
$1.98B |
2.06 |
| 2012-06-30 |
$4.05B |
$1.89B |
2.14 |
| 2012-03-31 |
$3.98B |
$1.62B |
2.46 |
| 2011-12-31 |
$4.43B |
$1.61B |
2.76 |
| 2011-09-30 |
$3.42B |
$1.82B |
1.88 |
| 2011-06-30 |
$3.74B |
$1.66B |
2.26 |
| 2011-03-31 |
$3.58B |
$1.58B |
2.27 |
| 2010-12-31 |
$3.76B |
$1.61B |
2.33 |
| 2010-09-30 |
$3.36B |
$1.67B |
2.01 |
| 2010-06-30 |
$3.00B |
$1.53B |
1.96 |
| 2010-03-31 |
$2.77B |
$1.47B |
1.89 |
| 2009-12-31 |
$2.89B |
$1.54B |
1.88 |
| 2009-09-30 |
$3.49B |
$1.78B |
1.96 |
| 2009-06-30 |
$3.29B |
$1.65B |
2.00 |
| 2009-03-31 |
$2.23B |
$1.51B |
1.47 |
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
Medical & Dental Supplies |
$67.086B |
$19.372B |
|
Becton, Dickinson and Company, is a medical technology company engaged principally in the development, manufacture and sale of medical devices, instrument systems and reagents. BD's operations consisted of three business segments: BD Medical, BD Diagnostics and BD Biosciences. The company's organizational structure was realigned to form two principal business segments: BD Medical, BD Life Sciences and BD Interventional. BD Medical: BD Medical's major product lines include needles, syringes and intravenous catheters for medication delivery and generic prefilled injectables. BD Life Sciences - BD Diagnostics provides products for the safe collection and transport of diagnostics specimens to detect a broad range of infectious diseases, healthcare-associated infections and cancer. BD Biosciences produces research and clinical tools that facilitate the study of cells to gain a better understanding of normal and disease processes. With the acquisition of C.R. Bard, BD added a new segment - BD Interventional.
|
